U

United Medical Research Institute | Inglewood, CA

Research site
(Unclaimed)
Location
431-433 North Prairie Avenue, Inglewood, California, United States of America

Site insights

Top conditions

Top treatments

Latanoprost
AR-12286
AGN-190584
KPI-121
AR-13324
Netarsudil
ISV-502
K-321
PG286
PG043

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 27 total trials

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

The investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-...

Enrolling
Thyroid Eye Disease
Drug: VRDN-001 10 mg/kg
Drug: VRDN-001 3 mg/kg

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the...

Enrolling
Open-angle Glaucoma
Ocular Hypertension
Other: Lumigan Vehicle
Other: Lumigan

The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects...

Begins enrollment in 2 months
Open Angle Glaucoma
Ocular Hypertension
Drug: AR-17043 Ophthalmic Solution
Drug: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

Active, not recruiting
Pterygium
Drug: RMP-A03 - Dose 1
Drug: RMP-A03 - Dose 2

Trial sponsors

Aerie Pharmaceuticals logo
AbbVie logo
Allergan logo
K
Kowa logo
Alcon logo
E
E
F
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems